Impact of socioeconomic individual and ecological factors on extreme diagnosis-to-treatment interval in diffuse large B-Cell lymphoma in the French real-world cohort REALYSA
In this large real-world cohort of newly diagnosed DLBCL patients, age, occupational status, and patients' pathway were linked to very long delays to treatment. Interventions to streamline DTIs, especially for older and/or blue-collar or farmer patients, and for those changing facility of treatment, are warranted to improve quality of care.
Authors
- Sandra Le Guyader Peyrou
- Loïc Ysebaert (ORCID: https://orcid.org/0000-0003-4102-7261)
- Alexandre Bélot (ORCID: https://orcid.org/0000-0003-4902-5332)
- Côme Bommier (ORCID: https://orcid.org/0000-0002-5695-911X)
- Fontanet Bijou (ORCID: https://orcid.org/0000-0001-6768-7175)
- Hervé Ghesquières (ORCID: https://orcid.org/0000-0002-3131-3718)
- Cédric Rossi
- C. Cantrelle (ORCID: https://orcid.org/0000-0002-3737-1126)
- Hadia Khebbeb Hafirassou
- Alain Monnereau (ORCID: https://orcid.org/0000-0002-5056-1397)
- Ludovic Fouillet (ORCID: https://orcid.org/0009-0007-3281-5043)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Université de Bordeaux (FR)
- Inserm (FR)
- Institut universitaire du cancer de Toulouse Oncopole (FR)
- Bordeaux Population Health (FR)
- The Lymphoma Academic Research Organisation (FR)
- Institute Cancer De La Loire Lucien Neuwirth (FR)
- Hôpital Lyon Sud (FR)
- Institut Bergonié (FR)
- Hôpital Saint-Louis (FR)
Publication Details
- Journal
- Cancer Epidemiology
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1016/j.canep.2025.102875
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Amgen
- Bristol-Myers Squibb
- AstraZeneca
- Celgene
- Institut National de la Santé et de la Recherche Médicale
- Ligue Contre le Cancer
- Hospices Civils de Lyon